好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Pilot Study of Ralfinamide in the Treatment of Patients with Neuropathic Pain (NP)
Headache and Pain
(-)
154
Authors/Disclosures
Raed Alroughani, MD, FAAN Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
No disclosure on file
No disclosure on file
Samar F. Ahmed, MD Dr. Ahmed has nothing to disclose.
No disclosure on file
Jasem Y. Al-Hashel, MD (IBN Sina Hospital, AlSabah Medical Area, Neurology Department) Dr. Al-Hashel has nothing to disclose.